x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
Blog

Can Ethics Review Catch Up to the CBD Craze?

CBD, a non-psychoactive cannabinoid, is experiencing a massive surge in popularity, but clinical research lags behind in verifying effective uses.

Read Now
4 min. read
Read more
 
Blog

Quorum/Kinetiq Acquisition & Integration:
What You Need to Know

On March 5, 2019, Advarra announced its acquisition of Quorum Review IRB and Kinetiq, the research and technology consulting division of Quorum.

Read Now
Read more
 
Blog

After the Compliance Date: Revised Common Rule FAQs (Or: Why We Cancelled Our February Webinar)

We have cancelled our webinar “After the Compliance Date: Revised Common Rule FAQs,” which was originally scheduled for February 28.

Read Now
Read more
 
Blog

Informed Consent Changes in the Revised Common Rule

If your research must comply with the revised Common Rule, you’ll need to update the way you write ICFs to meet the new requirements.

Read Now
4 min. read
Read more
 
Blog

Do I Need to Comply With the Revised Common Rule?

While many US researchers are aware of the coming Common Rule changes, not everyone is sure whether they will need to comply with the revised regulations.

Read Now
4 min. read
Read more
 
Blog

Reporting to the IRB: Serious Adverse Events (SAEs) in Drug Studies

Learn what the regulations say about IRB reporting requirements for serious adverse events and how undefined “gray areas” can be addressed.

Read Now
5 min. read
Read more
 
Blog

Infection Control and Biosafety in Gene Therapy Research

Given the growth in gene therapy research, sponsors, CROs and sites have become increasingly curious about the requirements to be able to conduct such studies.

Read Now
4 min. read
Read more
 
Blog

Integration Update: Leading Compliance Adherence

The Advarra team is proud to announce that all major integration activities are now complete.

Read Now
3 min. read
Read more
 
Blog

What’s the Difference Between Right to Try and Expanded Access?

Let’s take a look at the basics of what each program does and does not do for patients seeking to access investigational therapies.

Read Now
5 min. read
Read more
 
Blog

Integration Update: Recent Milestones Completed

The Advarra team has worked to fully integrate our processes and policies to provide clients with unified capabilities and support for IRB, IBC and global research quality and compliance consulting services.

Read Now
4 min. read
Read more
 
Blog

Integration Update: Expanded FAQ for Advarra Merger Efforts

The following FAQ expands upon previous FAQs we’ve published and provides additional insight into the integration process.

Read Now
15 min. read
Read more
 
Blog

International Research and Research Ethics Review

Clinical research continues to grow throughout the world, with researchers looking outside the US for new and diverse subject populations to help develop and improve investigational therapies. Lauri Carlile, VP of Operations at Advarra, discusses the basics of ex-US research ethics review for US-based researchers.

Read Now
3 min. read
Read more